Bill > HB1052

This bill mandates that health benefit plans in Arkansas provide coverage for monoclonal antibodies used to immunize infants against respiratory syncytial virus (RSV) disease, starting January 1, 2026. Specifically, the bill requires that all health benefit plans, including state and federal programs like Arkansas Medicaid, cover monoclonal antibody immunizations for infants under 8 months old, following United States Food and Drug Administration guidelines. The coverage must be provided without annual deductibles, copayments, or coinsurance limits, and cannot reduce other existing health plan benefits. The bill defines key terms such as "health benefit plan" (which includes various types of health insurance and state health programs) and "respiratory syncytial virus disease" (a respiratory infection affecting the nose, throat, and lungs). Additionally, the bill mandates that the Insurance Commissioner, Department of Human Services Secretary, and State Board of Finance develop and file necessary implementation rules by January 1, 2026, ensuring a smooth rollout of the new coverage requirement.

Health and Social Services

https://www.arkleg.state.ar.us/Bills/Detail?id=hb1052&ddBienniumSession=2025%2F2025R